Nipro Corporation (FRA:5FA)

Germany · Delayed Price · Currency is EUR

7.50

+0.05 (0.67%)

Last updated: Oct 23, 2026, 5:15 PM CEST

Market Cap	1.27B -10.4%
Revenue (ttm)	3.60B +2.7%
Net Income	75.78M +144.4%
EPS	0.44 +145.3%
Shares Out	n/a
PE Ratio	17.20
Forward PE	n/a
Dividend	0.17 (2.27%)
Ex-Dividend Date	Sep 29, 2026

Volume	4,800
Open	7.50
Previous Close	7.45
Day's Range	7.50 - 7.50
52-Week Range	7.20 - 9.25
Beta	n/a
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 10, 2026

About Nipro

Nipro Corporation, together with its subsidiaries, engages in the medical devices, pharmaceuticals, and pharma packaging businesses worldwide. The company offers renal products; interventional products, such as cardiovascular products, endovascular products, and accessories; and hospital products, including hypodermic needles, syringes, IV sets and catheters, 3-way stopcocks, infusion sets, balloon infusers, etc. It also provides cardiopulmonary products comprising oxygenators, cardioplegia heat exchangers, perfusion tubing sets, arterial filte... [Read more]

Industry Medical Instruments & Supplies

Sector Healthcare

Founded 1947

Employees 38,593

Stock Exchange Frankfurt Stock Exchange

Ticker Symbol 5FA

Financial Performance

In fiscal year 2026, Nipro's revenue was 660.54 billion, an increase of 2.47% compared to the previous year's 644.59 billion. Earnings were 13.50 billion, an increase of 164.11%.

Financial numbers in JPY Financial Statements